The Honest Company Earnings Call Transcripts
Fiscal Year 2026
-
Q3 organic revenue rose 9.2%, with record underlying adjusted gross margin of 48.9% and adjusted EBITDA of $6.3 million. FY2026 guidance was raised, and a new share repurchase program of up to $30 million was authorized.
-
Q2 2026 saw 6.7% organic revenue growth and record underlying margins, driven by strong Wipes and Personal Care performance, while diapers faced structural headwinds. Full-year guidance was raised, with continued investments in marketing and operational efficiency.
-
The meeting opened with board introductions and proceeded to two proposals: electing three directors and ratifying the auditor. Both proposals passed with a quorum present, and no questions were raised by shareholders during the session.
-
Q1 2026 saw 3.9% organic revenue growth and record adjusted gross margin of 43.5%, led by wipes and personal care. Household penetration reached 8.1%, while diaper declines moderated. Full-year guidance is reaffirmed, with strong cash flow and continued investment in marketing.
Fiscal Year 2025
-
Organic revenue grew 5.3% in 2025, driven by wipes and personal care, while diapers declined due to retailer shifts and consumer trade-down. 2026 guidance calls for 4%-6% organic growth, margin expansion, and continued innovation, supported by a strong balance sheet and a $25M share repurchase program.
-
Q3 revenue fell 7% year-over-year due to Diapers and Apparel declines, but Wipes and Personal Care saw double-digit growth. Transformation 2.0 will exit low-margin businesses, focus on core categories, and drive cost savings, with organic revenue expected to grow 4%-6% in 2025.
-
Delivered record gross margin and second consecutive quarter of positive net income, with revenue of $93 million and strong growth in wipes and personal care segments. Reaffirmed full-year outlook despite tariff and macroeconomic headwinds, supported by new product launches and expanded distribution.
-
Q1 2025 saw 13% revenue growth, gross margin expansion to 39%, and $3M net income, driven by strong wipes and sensitive skin portfolios. Despite diaper headwinds and tariff risks, full-year guidance is reaffirmed, with ongoing investment in brand and margin initiatives.
-
A focused transformation initiative drove double-digit revenue growth, margin expansion, and positive earnings, supported by portfolio optimization and expanded distribution. Significant opportunities remain for hero products and further retail penetration, with a strong market position in clean, modern personal care.
Fiscal Year 2024
-
Record 2024 results included 10% revenue growth, 900 bps gross margin expansion, and first full year of positive adjusted EBITDA. 2025 guidance calls for 4%-6% revenue growth and further margin gains, with continued focus on distribution, innovation, and cost discipline.
-
Q3 2024 saw record revenue of $99M (up 15% YoY), gross margin expansion to 39%, and positive Adjusted EBITDA for the fourth straight quarter. Full-year guidance was raised for both revenue and Adjusted EBITDA, with strong growth in baby products, wipes, and digital channels.
-
Inflation is easing in consumer goods, with strong demand for quality personal care and sensitive skincare products. Record revenue and margin expansion were achieved, and guidance was raised as digital and omnichannel strategies drive growth.
-
Record Q2 revenue of $93M (up 10% YoY) and gross margin of 38% drove positive Adjusted EBITDA and cash flow. Full-year guidance was raised for both revenue and Adjusted EBITDA, with growth led by baby personal care, wipes, and e-commerce, despite competitive diaper category pressures.
-
Transformation initiatives led to improved financial stability, positive EBITDA, and margin expansion. Growth is driven by retail distribution, especially at Walmart, Target, and Amazon, with hero SKUs and clean product positioning fueling portfolio success. Household penetration and shelf presence offer significant upside.